The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 17th 2025
The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50 and older.
Oral Semaglutide Demonstrates Benefits for Patients With Type 2 Diabetes
September 20th 2018A global phase 3a trial successfully demonstrated greater reductions in HbA1c and body weight with a oral semaglutide drug treatment than with dulaglutide, as well as a a comparable number of adverse events in 458 Japanese adults with type 2 diabetes between these medications.
Read More
Pharmacies Assisting Communities Impacted by Hurricane Florence With Digital Tools, Donations
September 18th 2018Pharmacies closed by Hurricane Florence are working to re-open, as customers are being directed to open stores, and some pharmacies are going even further to assist staff and customers as they recover from the storm's impact.
Read More
Hereditary Angioedema: The Pharmacist's Role in Team-Based Patient Care
As medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care.
Read More
Daily Probiotics May Reduce Kids' Need for Antibiotics
September 14th 2018As growing levels of antibiotic resistance continues to concern health care professionals, the results of a recent study suggest that giving daily probiotic supplements to children can reduce their likelihood of requiring antibiotics.
Read More
Pharmacists In Position to Impact Change for Hepatitis C
September 14th 2018Presenters at the International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland identified the current landscape of Hepatitis C, how pharmacists can position themselves to aid in point of care testing, and ways to better educate patients and providers.
Read More
New Treatment for Hairy Cell Leukemia Granted FDA Approval
September 14th 2018Officials with the FDA have approved AstraZeneca’s moxetumomab pasudotox-tdfk (Lumoxiti) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least 2 prior systemic therapies.
Read More
Study Shows Azathioprine Linked to Increased Skin Cancer Risk
September 12th 2018Azathioprine is known to cause increased photosensitivity to UVA light, but the new findings indicate an association between the drug and the mutational signature found in cases of cutaneous squamous cell carcinoma.
Read More
Pharmacogenomics: Implementation in Pharmacy Practice
September 9th 2018At the International Pharmaceutical Federation (FIP) World Congress in Glasgow Scotland, speakers reviewed principles of pharmacogenomics and demonstrated useful strategies for utilizing pharmacogenomics in a clinical setting.
Read More